Biotech Shares Rip Following Collaboration Announcement For Monkeypox Research

By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, October 22, 2024

A Scotland-based biotech company is finding a tremendous amount of success so far during Tuesday’s session after the company announced it entered into a research planning collaboration with Dr. Carlos Maluquer de Motes for the development of a treatment for Monkeypox.

Traders were quick to buy up shares of TC BioPharm (Holdings) plc (Nasdaq:TCBP) following the announcement, with shares of this micro cap quickly reaching up to $3.8799/share (+70.92%) at the early session high. This move could be indicative of this stock finally finding support for the first time in quite some time.

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Battery Company Moving Higher Following LOI for Joint Venture

Acquisition Of 80-Megawatt Bitcoin Mining Facility Causes Massive Buying Pressure

Biotech Shares Rip Following Collaboration Announcement For Monkeypox Research

Monday Action on News of $2 Million in Defense Orders

Holding Company Shares Rally Following Board Of Directors Commentary

Junior Miner Trading Higher on Reorganization Plans

With inflation below target, BoC expected to deliver supersized rate cut this week

Tobacco companies unlikely to shift business models despite proposed settlement: prof

AllPennyStocks.com Favorites

Equities Rally on Earnings Beats

Enable Free Access to Unlock Up to Two Articles Per Month.

This Exciting Biotech Is Setting Up For A Nearly 5:1 Risk:Reward Trade

Enable Free Access to Unlock Up to Two Articles Per Month.

Akebia Therapeutics Inc. looks promising from a technical analysis perspective as the Nasdaq listed stock displayed what technicians call a Golden Cross (50 DMA / 200 DMA) on Tuesday. Shares closed at $1.64.

Copper Road Resources Inc. was an impressive gainer on the TSX-Venture on Tuesday. Shares climbed 200.00%, settling at $0.045.

Trading on the Nasdaq, Ensysce Biosciences Inc. rallied 161.65%, closing at $0.54 on Tuesday.

Cutting-Edge Brain Therapy Signals Big Upside for Investors

Enable Free Access to Unlock Up to Two Articles Per Month.

Silver Miner Ripping Higher As Major Resistance Level Gets Broken To The Upside

Enable Free Access to Unlock Up to Two Articles Per Month.

WANT TO UNLOCK ACCESS TO:

●Stock Picks

●Penny Stocks to Watch

●Market Commentary

●Watch Lists

And much more by becoming an AllPennyStocks.com Free Member.

Free Membership Has Its Perks!

By entering your email address, you agree to AllPennyStocks.com’s disclaimer and privacy policy.

Register via:

You understand that AllPennyStocks.com and its affiliates may use your address to send updates, ads and offers.

Go Back

Email Registration

By clicking on the "Start Viewing AllPennyStocks.com Pro Articles" button below, you are confirming that you understand and accept that the content we are showing you is not meant to be used as financial advice. This content is merely for educational purposes and shows our readers real-time examples of trading strategies based on technical and fundamental analysis principles, along with stock market commentary.

Investing in stocks is risky stuff, trust us on that one, and past performance may not be indicative of future performance.

We want everyone to enjoy this information for its educational value, and we remind everyone that we are not liable for losses or damages of any kind from trading based on our information. The only thing we will recommend is to consult with a financial advisor prior to making any trades.

With that said, if we're on the same page here and you agree to our disclaimer, click the button below and enjoy all of our AllPennyStocks.com Pro content.

© Copyright 2024 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.

Biotech Shares Rip Following Collaboration Announcement For Monkeypox Research

Other Penny Stock Movers

Battery Company Moving Higher Following LOI for Joint Venture

Acquisition Of 80-Megawatt Bitcoin Mining Facility Causes Massive Buying Pressure

Biotech Shares Rip Following Collaboration Announcement For Monkeypox Research

Most Popular

AllPennyStocks.com Favorites